As of 2026-03-16, the Relative Valuation of Acceleron Pharma Inc (XLRN) is (90.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 178.75 USD, the upside of Acceleron Pharma Inc based on Relative Valuation is -150.4%.
The range of the Relative Valuation is (81.38) - (95.90) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 23.1x | 21.1x |
| Forward P/E multiples | 19.3x - 22.7x | 21.6x |
| Fair Price | (81.38) - (95.90) | (90.12) |
| Upside | -145.5% - -153.6% | -150.4% |
| Date | P/E |